Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,621 to 1,640 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise. | Microorganisms | 2021 | 34198973 | PubTator, text mining | PubMed |
| The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs. | Front Cell Dev Biol | 2021 | 34195201 | PubTator, text mining | PubMed |
| Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies. | Sci Adv | 2021 | 34193418 | PubTator, text mining | PubMed |
| Development and validation of a risk prediction model and nomogram for colon adenocarcinoma based on methylation-driven genes. | Aging (Albany NY) | 2021 | 34182539 | PubTator, text mining | PubMed |
| Identification of Key Genes and Pathways in Gefitinib-Resistant Lung Adenocarcinoma using Bioinformatics Analysis. | Evol Bioinform Online | 2021 | 34177255 | PubTator, text mining | PubMed |
| The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination. | Cell | 2021 | 34174187 | PubTator, text mining | PubMed |
| Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury. | World J Gastroenterol | 2021 | 34168400 | PubTator, text mining | PubMed |
| The cellular architecture of the antimicrobial response network in human leprosy granulomas. | Nat Immunol | 2021 | 34168371 | PubTator, text mining | PubMed |
| Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19. | Cell Death Dis | 2021 | 34168124 | PubTator, text mining | PubMed |
| Genetic Signatures From RNA Sequencing of Pediatric Localized Scleroderma Skin. | Front Pediatr | 2021 | 34164359 | PubTator, text mining | PubMed |
| A Distinct Innate Immune Signature of Early Onset Colorectal Cancer. | Immunohorizons | 2021 | 34162701 | PubTator, text mining | PubMed |
| Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options. | Biomed Pharmacother | 2021 | 34153851 | PubTator, text mining | PubMed |
| Adipose-derived stem cells therapy effectively attenuates PM2.5-induced lung injury. | Stem Cell Res Ther | 2021 | 34147136 | PubTator, text mining | PubMed |
| Ppp6c deficiency accelerates K-rasG12D -induced tongue carcinogenesis. | Cancer Med | 2021 | 34145991 | PubTator, text mining | PubMed |
| Bioinformatics, Molecular Docking and Experiments In Vitro Analyze the Prognostic Value of CXC Chemokines in Breast Cancer. | Front Oncol | 2021 | 34123826 | PubTator, text mining | PubMed |
| Acute Experimental Barrier Injury Triggers Ulcerative Colitis-Specific Innate Hyperresponsiveness and Ulcerative Colitis-Type Microbiome Changes in Humans. | Cell Mol Gastroenterol Hepatol | 2021 | 34118489 | PubTator, text mining | PubMed |
| Identification of Disease-Specific Hub Biomarkers and Immune Infiltration in Osteoarthritis and Rheumatoid Arthritis Synovial Tissues by Bioinformatics Analysis. | Dis Markers | 2021 | 34113405 | PubTator, text mining | PubMed |
| Colorectal Carcinoma Affected Patients Are Significantly Poor Responders Against the Oncogenic JC Polyomavirus. | Front Immunol | 2021 | 34113338 | PubTator, text mining | PubMed |
| Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer. | Curr Treat Options Oncol | 2021 | 34110510 | PubTator, text mining | PubMed |
| Identification and treatment of T2-low asthma in the era of biologics. | ERJ Open Res | 2021 | 34109244 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=82